Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,767,364,935
-
Total 13F shares
-
1,067,427,836
-
Share change
-
+11,819,887
-
Total reported value
-
$94,486,529,954
-
Put/Call ratio
-
114%
-
Price per share
-
$88.54
-
Number of holders
-
2,231
-
Value change
-
+$1,223,798,676
-
Number of buys
-
962
-
Number of sells
-
880
Institutional Holders of AbbVie Inc. - Common Stock (ABBV) as of Q4 2019
As of 31 Dec 2019,
AbbVie Inc. - Common Stock (ABBV) was held by
2,231 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,067,427,836 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., Capital Research Global Investors, STATE STREET CORP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, JPMORGAN CHASE & CO, and Orbis Allan Gray Ltd.
This page lists
2,232
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.